133 related articles for article (PubMed ID: 15843999)
1. Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance.
Bamgbola OF; del Rio M; Kaskel FJ; Flynn JT
Pediatr Nephrol; 2005 Jul; 20(7):989-93. PubMed ID: 15843999
[TBL] [Abstract][Full Text] [Related]
2. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center.
Hyman G; England M; Kibede S; Lee P; Willets G
Nephron Clin Pract; 2004; 96(2):c39-42. PubMed ID: 14988596
[TBL] [Abstract][Full Text] [Related]
4. Reteplase for dysfunctional hemodialysis catheter clearance.
Hilleman DE; Dunlay RW; Packard KA
Pharmacotherapy; 2003 Feb; 23(2):137-41. PubMed ID: 12587800
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters.
Daeihagh P; Jordan J; Chen J; Rocco M
Am J Kidney Dis; 2000 Jul; 36(1):75-9. PubMed ID: 10873875
[TBL] [Abstract][Full Text] [Related]
6. The use of tissue plasminogen activator infusion to re-establish function of tunneled hemodialysis catheters.
Dowling K; Sansivero G; Stainken B; Siskin G; Dolen E; Ahn J; Mitchell N
Nephrol Nurs J; 2004; 31(2):199-200. PubMed ID: 15114800
[TBL] [Abstract][Full Text] [Related]
7. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.
Savader SJ; Haikal LC; Ehrman KO; Porter DJ; Oteham AC
J Vasc Interv Radiol; 2000 Oct; 11(9):1131-6. PubMed ID: 11041468
[TBL] [Abstract][Full Text] [Related]
9. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator (t-PA) efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
CANNT J; 1999; 9(4):25-8. PubMed ID: 15714785
[TBL] [Abstract][Full Text] [Related]
11. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
Shea M; Hmiel SP; Beck AM
Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
[TBL] [Abstract][Full Text] [Related]
12. Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.
Wójtowicz D; Cholewa D; Faba AM; Domańska B; Kokoszka J; Kopacz K; Ficek R; Irzyniec T; Rotkegel SE; Chudek J
Ren Fail; 2018 Nov; 40(1):384-389. PubMed ID: 30010473
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath.
Schenk P; Rosenkranz AR; Wölfl G; Hörl WH; Traindl O
Am J Kidney Dis; 2000 Jan; 35(1):130-6. PubMed ID: 10620554
[TBL] [Abstract][Full Text] [Related]
14. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of reteplase in poorly functioning hemodialysis catheters.
Falk A; Samson W; Uribarri J; Vassalotti JA
Clin Nephrol; 2004 Jan; 61(1):47-53. PubMed ID: 14964457
[TBL] [Abstract][Full Text] [Related]
16. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
Castner D
Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
[TBL] [Abstract][Full Text] [Related]
18. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
19. A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3.
Tumlin J; Goldman J; Spiegel DM; Roer D; Ntoso KA; Blaney M; Jacobs J; Gillespie BS; Begelman SM
Clin J Am Soc Nephrol; 2010 Apr; 5(4):631-6. PubMed ID: 20133491
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator as a hemodialysis catheter locking solution.
McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
